Logo image
Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents
Journal article   Open access   Peer reviewed

Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents

Hiroto Araki, Nadim Mahmud, Mohammed Milhem, Rafael Nunez, Mingjiang Xu, Craig A. Beam and Ronald Hoffman
Experimental hematology, Vol.34(2), pp.140-149
2006
DOI: 10.1016/j.exphem.2005.10.002
PMID: 16459182
url
https://doi.org/10.1016/j.exphem.2005.10.002View
Published (Version of record) Open Access

Abstract

We investigated whether the addition of two chromatin-modifying agents, 5-aza-2′-deoxycytidine (5azaD) and trichostatin A (TSA), to cord blood (CB) CD34 + cells in culture results in expansion of the numbers of severe combined immunodeficient (SCID) repopulating cells (SRC). Human CB CD34 + cells were cultured with cytokines in the presence or absence of 5azaD/TSA. After 9 days of culture, the fold expansion of CD34 + and CD34 +CD90 + cell numbers, colony-forming unit (CFU)-mix, cobblestone area-forming cell (CAFC), and SRC numbers were determined. A 12.5-fold expansion of CD34 +CD90 + cells was observed in the 5azaD/TSA-treated cultures in comparison to the input cell numbers. Expansion of CD34 +CD90 + cells was associated with a 9.8-fold increase in the numbers of CFU-mix and 11.5-fold increase in CAFC. 5azaD/TSA treatment of the CB CD34 + cells resulted in a 9.6-fold expansion of the absolute number of SRC following 9 days of culture as determined by limiting dilution analysis. Expansion of cells maintaining CD34 +CD90 + phenotype was not due to the retention of a quiescent population of cells because all of the CD34 +CD90 + cells in the culture had undergone cellular division. 5azaD/TSA-treated CD34 +CD90 + cells, but not CD34 +CD90 − cells were responsible for in vivo hematopoietic repopulation potential of nonobese diabetic/SCID mice. Ex vivo expansion strategy using chromatin-modifying agents provides a potential avenue by which to expand the number of hematopoietic stem cells (HSC) with a single CB unit for use as an alternative source of HSC grafts for adult recipients.

Details

Metrics

Logo image